# OptimizeRx Corp: Form 8-K, filed Jun 5, 2026

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: 8-K
- Filed: 2026-06-05
- Accepted by EDGAR: Jun 5, 2026, 20:10 ET
- Period: 2026-06-01
- Accession: 0001213900-26-065810
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/ea0293598-8k_optimize.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/ea0293598-8k_optimize.htm

Filed Jun 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-065810. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.